Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway

Jibo Han(Wenzhou Medical University), Jianjiang Xu(SUNY Downstate Health Sciences University)
Drug Design Development and Therapy
November 1, 2018
Cited by 19


Related Papers